Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Dec 15, 2025
Reporting period
Not applicable
Filed with the SEC
Dec 17, 2025
CFOOption exercise
Context
Classification
option exercise
Code M — exercise or conversion of a derivative security
Planned / mechanical clue
Footnote references tax withholding
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001533302-25-000011
Filed / recorded
Dec 17, 2025, 9:58 PM UTC
Added to OQRO
Oct 7, 2026, 5:52 AM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
SPRUCE BIOSCIENCES, INC.
Issuer CIK
1683553
Ticker
SPRB
Reporting person
Samir M. Gharib
Relationship
Officer
Officer title
PRESIDENT AND CFO
Security
Common Stock
Table
Non-derivative (Table I)
Transaction date
Dec 15, 2025
Transaction code
M
Shares / units
513
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
8,447
Ownership form
Direct
Amendment
No
Footnotes from the filing
On December 14, 2023, the Reporting Person was granted a total of 4,106 RSUs. 50% or 2,053 of the total RSUs are performance-based and all vested on December 10, 2024. An addition of 50% or 2,053 of the total RSUs are time-based. 25% of which vested on December 15, 2024, and in equal annual installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan). On December 15, 2025, 513 shares vested and 184 shares were withheld for taxes, resulting in a net issuance of 329 shares.
Each RSU represents a contingent right to receive one share of common stock of the Issuer.